Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells

DENG Shi, YANG Bo, REN Zheng-ju. et al

Abstract

To detect the expression and growth regulation effects of the factor inhibiting hypoxia- inducible factor (P'IH-1) in renal carcinoma cells. Methods The expressions of FIH-1, hypoxia inducible factor (HIF) and vascular endothelial growth factor (VEGF) were examined in OS-RC-2 and 786-0 cell lines via real-time PCR (RT-PCR) and Western blot. Overexpression plasmid of FIH-1 were designed and constructed as EX-V1104- M45-F/H-1. After the transfection of the plasmid into OS-RC-2 and 786-0 cells, the expression levels of FIH-1, HIF and VEGF were measured by RT-PCR and Western blot, while cell proliferation was tested by MTT. Results The expressions of FIH-1, HIF-la, HIF-2a and VEGF were detected in OS-RC-2 cells, and FIH-1, HIF-2a and VEGF were detected in 786-0 cells. After the transfection of EX-VI 104-M45-F/H-1, the level of FIH-1 was increased in OS-RC-2, while the levels of HIF-2a, HIF-la and VEGF were decreased. MTT showed that FIH-1 plasmid transfection decreased the cell proliferation of OS-RC-2, but did not show inhibition on 786-0 cells proliferation. Conclusion FIH-1/HIF-la/VEGF signaling pathway exists in renal carcinoma cell lines.

 

Keywords: Renal cell carcinoma, Factor inhibiting hypoxia-inducible factor-1 Hypoxia inducible factor, RNA

Full Text:

PDF


References


GNARRA JR. TORY K, WENG Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet, 1994.7(1):85-90.

COPPIN C, PORZSOLT F. AWA A. et al. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev. 2005(1 );CD001425.

MAXWELL PH. Oxygen homeostasis and cancer: insights from a rare disease. Clin Med,2002,2(4);356-362.

EPSTEIN AC, GLEADLE JM, MCNEILL LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 2001, 107(1):43-54.

KOIVUNEN P. HI RSI LA M. GUNZLER V. et al. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem, 2004, 279 ( 11 ); 9899- 9904.

SEMENZA GL, WANG GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992,12( 12); 5447- 5454.

CARMELIET P. DOR Y. HERBERT JM. et al. Role of HIF-lalpha in hypoxia-mediated apoptosis. cell proliferation and tumour angiogenesis. Nature,1998,394(6692);485-490.

CREWS ST. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev, 1998, 12 (5):607-620.

HARRIS AL. Hypoxia a key regulatory factor in tumour growth. Nat Rev Cancer,2002,2( 1) :38-47.

KHAN MN, BHATTACHARYYA T, ANDRIKOPOULOS P, et al. Factor inhibiting HIF ( FIH-1 ) promotes renal cancer cell survival by protecting cells from HIF-1 alpha- mediated apoptosis. Br J Cancer,2011,104(7): 1151-1159.

WIESENER MS, TURLEY H. ALLEN WE. et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1 alpha. Blood, 1998, 92 ( 7 ); 2260- 2268.

TIAN H, MCKNIGHT SL, RUSSELL DW. Endothelial PAS domain protein 1 ( EPAS1 )» a transcription factor selectively expressed in endothelial cells. Genes Dev, 1997,11 (1):72-82.

IVAN M, KONDO K, YANG H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation; implications for 02 sensing. Science, 2001, 292 ( 5516): 464- 468.

MAXWELL PH, WIESENER MS, CHANG GW. et al. The tumour suppressor protein VHL targets hypoxia- inducible factors for oxygen-dependent proteolysis. Nature, 1999,399(6733):271-275.

DOU QH.CHEN HN.WANG К, et al. Ivermectin induces cytostatic autophagy by blocking the PAKl/Akt axis in breast cancer. Cancer Res.2016.76( 15) :4457-4469.

CHEN W.ZHENG R. BAADE PD,et al. Cancer statistics in China 2015. CA Cancer J Clin,2016.66(2): 115-132.

XUE T. SU J. LI H, et al. Evaluation of HAAH/humbug quantitative detection in the diagnosis of hepatocellular carcinoma. Oncol Rep,2015,33( 1) :329-337.

LEE JH. Overexpression of humbug promotes malignant progression in human gastric cancer cells. Oncol Rep. 2008. 19(3):795-800.

DONG X.LIN Q.AIHARA A, et al. Aspartate-hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget.2015,6(2): 1231-1248.

KORIOTH F. GIEFFERS C, FREY J. Cloning and characterization of the human gene encoding aspartyl beta- hydroxylase. Gene, 1991,150(2);395-399.

STURLA LM. TONG M, HEBDA N. et al. Aspartate-p- hydroxylase (ASPH): a potential therapeutic target in human malignant gliomas. Heliyon, 2016, 2 ( 12): e00203 [2016-11-21]. https://doi. org/10. 1016/j. heliyon. 2016. e00203.

DEBIES MT, WELCH DR. Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia,2001,6 (4):441-451.


Refbacks

  • There are currently no refbacks.